 James Roede
Concepts (300)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 6 | 2023 | 338 | 3.110 |
Why?
| | Mitochondria | 10 | 2023 | 751 | 2.540 |
Why?
| | Maneb | 4 | 2020 | 7 | 2.200 |
Why?
| | Induced Pluripotent Stem Cells | 3 | 2023 | 182 | 2.050 |
Why?
| | Sulfhydryl Compounds | 7 | 2023 | 177 | 1.800 |
Why?
| | Liver | 10 | 2021 | 1634 | 1.150 |
Why?
| | Aldehydes | 8 | 2017 | 142 | 1.010 |
Why?
| | Thioredoxins | 8 | 2018 | 33 | 1.000 |
Why?
| | Peroxiredoxin VI | 3 | 2009 | 5 | 0.970 |
Why?
| | Glutathione | 10 | 2023 | 300 | 0.970 |
Why?
| | Pesticides | 2 | 2018 | 49 | 0.970 |
Why?
| | Parkinson Disease | 3 | 2020 | 323 | 0.960 |
Why?
| | Ethanol | 9 | 2023 | 548 | 0.930 |
Why?
| | Metabolome | 4 | 2018 | 283 | 0.900 |
Why?
| | Metabolomics | 5 | 2014 | 527 | 0.850 |
Why?
| | Energy Metabolism | 3 | 2020 | 724 | 0.810 |
Why?
| | Oxidation-Reduction | 12 | 2023 | 927 | 0.810 |
Why?
| | Neuroblastoma | 2 | 2020 | 132 | 0.790 |
Why?
| | Neural Stem Cells | 1 | 2023 | 115 | 0.770 |
Why?
| | Oxidative Stress | 14 | 2022 | 1084 | 0.750 |
Why?
| | Homocystinuria | 2 | 2021 | 62 | 0.740 |
Why?
| | Proteomics | 7 | 2023 | 844 | 0.740 |
Why?
| | Dinoprostone | 1 | 2021 | 184 | 0.700 |
Why?
| | Cyclooxygenase 2 | 1 | 2021 | 164 | 0.700 |
Why?
| | Mass Spectrometry | 5 | 2018 | 633 | 0.680 |
Why?
| | Simvastatin | 1 | 2020 | 59 | 0.680 |
Why?
| | SNARE Proteins | 1 | 2019 | 37 | 0.670 |
Why?
| | Pyruvaldehyde | 2 | 2019 | 27 | 0.640 |
Why?
| | Glycolysis | 2 | 2019 | 227 | 0.610 |
Why?
| | Sulfinic Acids | 1 | 2018 | 7 | 0.600 |
Why?
| | Aminobutyrates | 1 | 2018 | 32 | 0.590 |
Why?
| | Peroxiredoxins | 4 | 2018 | 23 | 0.580 |
Why?
| | Taurine | 1 | 2018 | 41 | 0.580 |
Why?
| | Proteostasis Deficiencies | 1 | 2017 | 6 | 0.580 |
Why?
| | Autophagy | 1 | 2019 | 234 | 0.580 |
Why?
| | Environmental Pollutants | 1 | 2018 | 110 | 0.550 |
Why?
| | Trisomy | 1 | 2017 | 68 | 0.550 |
Why?
| | Fibroblasts | 1 | 2021 | 839 | 0.530 |
Why?
| | Mitochondrial Proteins | 3 | 2015 | 219 | 0.500 |
Why?
| | Paraquat | 2 | 2014 | 14 | 0.490 |
Why?
| | Fungicides, Industrial | 1 | 2014 | 5 | 0.470 |
Why?
| | Cysteine | 4 | 2023 | 171 | 0.460 |
Why?
| | Callithrix | 1 | 2013 | 8 | 0.440 |
Why?
| | Cross-Linking Reagents | 2 | 2009 | 181 | 0.380 |
Why?
| | Neurotoxins | 1 | 2011 | 26 | 0.380 |
Why?
| | Cell Line, Tumor | 5 | 2020 | 2725 | 0.370 |
Why?
| | Lipid Metabolism | 3 | 2015 | 446 | 0.360 |
Why?
| | Carbon | 2 | 2021 | 157 | 0.340 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2021 | 271 | 0.340 |
Why?
| | Mitochondrial Diseases | 1 | 2010 | 77 | 0.340 |
Why?
| | Humans | 36 | 2023 | 114937 | 0.340 |
Why?
| | Superoxides | 1 | 2010 | 214 | 0.330 |
Why?
| | Mice | 20 | 2023 | 14936 | 0.330 |
Why?
| | Liver Diseases, Alcoholic | 2 | 2011 | 83 | 0.330 |
Why?
| | Cystathionine beta-Synthase | 2 | 2021 | 59 | 0.320 |
Why?
| | Hydrogen Peroxide | 1 | 2010 | 287 | 0.310 |
Why?
| | Nanoparticles | 2 | 2023 | 313 | 0.300 |
Why?
| | Lysine | 3 | 2019 | 242 | 0.290 |
Why?
| | Animals | 24 | 2023 | 31839 | 0.290 |
Why?
| | Computational Biology | 3 | 2017 | 531 | 0.290 |
Why?
| | Reactive Oxygen Species | 3 | 2023 | 536 | 0.290 |
Why?
| | Antioxidants | 3 | 2013 | 530 | 0.280 |
Why?
| | Mice, Inbred C57BL | 12 | 2021 | 4719 | 0.270 |
Why?
| | Alcohol Drinking | 2 | 2011 | 655 | 0.270 |
Why?
| | Cells, Cultured | 3 | 2022 | 3897 | 0.260 |
Why?
| | Cell Differentiation | 2 | 2023 | 1699 | 0.250 |
Why?
| | Protein Carbonylation | 3 | 2017 | 51 | 0.240 |
Why?
| | Cell Line | 4 | 2023 | 2640 | 0.240 |
Why?
| | Male | 20 | 2021 | 55663 | 0.230 |
Why?
| | Mitochondria, Liver | 3 | 2014 | 67 | 0.230 |
Why?
| | Phenotype | 1 | 2012 | 2817 | 0.230 |
Why?
| | Tandem Mass Spectrometry | 6 | 2023 | 413 | 0.230 |
Why?
| | Blotting, Western | 3 | 2018 | 1151 | 0.220 |
Why?
| | Aging | 1 | 2013 | 1621 | 0.220 |
Why?
| | Saccharum | 1 | 2023 | 59 | 0.210 |
Why?
| | Hepatitis, Alcoholic | 1 | 2021 | 13 | 0.200 |
Why?
| | Superoxide Dismutase | 3 | 2017 | 305 | 0.190 |
Why?
| | Cyclooxygenase 1 | 1 | 2021 | 20 | 0.190 |
Why?
| | Cystathionine gamma-Lyase | 1 | 2020 | 11 | 0.190 |
Why?
| | Mast Cells | 1 | 2021 | 117 | 0.180 |
Why?
| | Thioredoxin-Disulfide Reductase | 2 | 2018 | 14 | 0.180 |
Why?
| | HT29 Cells | 2 | 2018 | 36 | 0.180 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 40 | 0.180 |
Why?
| | Mevalonic Acid | 1 | 2020 | 7 | 0.180 |
Why?
| | Methionine | 1 | 2021 | 144 | 0.180 |
Why?
| | Immunoglobulin E | 1 | 2021 | 317 | 0.170 |
Why?
| | Ubiquinone | 1 | 2020 | 21 | 0.170 |
Why?
| | Protein Transport | 2 | 2019 | 396 | 0.170 |
Why?
| | Thiolester Hydrolases | 1 | 2019 | 9 | 0.170 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2019 | 26 | 0.170 |
Why?
| | R-SNARE Proteins | 1 | 2019 | 18 | 0.170 |
Why?
| | Zebrafish | 1 | 2023 | 411 | 0.170 |
Why?
| | Zinc Oxide | 1 | 2019 | 9 | 0.170 |
Why?
| | Models, Animal | 2 | 2013 | 346 | 0.170 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2020 | 180 | 0.160 |
Why?
| | Female | 12 | 2021 | 59581 | 0.160 |
Why?
| | Lysosomes | 1 | 2019 | 123 | 0.160 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2019 | 91 | 0.160 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2018 | 474 | 0.160 |
Why?
| | Cell Survival | 2 | 2019 | 1022 | 0.160 |
Why?
| | Disease Models, Animal | 4 | 2021 | 3549 | 0.160 |
Why?
| | Microtubule-Associated Proteins | 1 | 2019 | 174 | 0.160 |
Why?
| | S-Nitrosothiols | 1 | 2018 | 4 | 0.150 |
Why?
| | gamma-Glutamyltransferase | 1 | 2018 | 42 | 0.150 |
Why?
| | Glutamate-Cysteine Ligase | 2 | 2023 | 17 | 0.150 |
Why?
| | Lipid Peroxidation | 4 | 2011 | 139 | 0.150 |
Why?
| | Electron Transport | 1 | 2018 | 108 | 0.150 |
Why?
| | Hepatitis | 1 | 2017 | 45 | 0.140 |
Why?
| | Mice, Transgenic | 3 | 2012 | 1953 | 0.140 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2017 | 31 | 0.140 |
Why?
| | Amino Acids | 2 | 2018 | 449 | 0.140 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 344 | 0.140 |
Why?
| | End Stage Liver Disease | 1 | 2017 | 63 | 0.140 |
Why?
| | Skin | 1 | 2021 | 659 | 0.130 |
Why?
| | Adenosine Triphosphate | 1 | 2018 | 431 | 0.130 |
Why?
| | Cochlea | 2 | 1994 | 90 | 0.130 |
Why?
| | Oxygen Consumption | 1 | 2018 | 588 | 0.130 |
Why?
| | Apoptosis | 3 | 2020 | 2371 | 0.130 |
Why?
| | Infant | 2 | 2019 | 7937 | 0.130 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 344 | 0.130 |
Why?
| | Recombinant Proteins | 2 | 2019 | 1233 | 0.130 |
Why?
| | Glycoproteins | 2 | 2021 | 305 | 0.120 |
Why?
| | Cholestasis | 1 | 2018 | 224 | 0.120 |
Why?
| | Gene Expression Regulation | 3 | 2019 | 2324 | 0.120 |
Why?
| | alpha-Linolenic Acid | 1 | 2014 | 7 | 0.120 |
Why?
| | Atrazine | 1 | 2014 | 8 | 0.120 |
Why?
| | Herbicides | 1 | 2014 | 24 | 0.120 |
Why?
| | Metabolic Networks and Pathways | 2 | 2013 | 168 | 0.120 |
Why?
| | Otoacoustic Emissions, Spontaneous | 1 | 1994 | 5 | 0.120 |
Why?
| | Endothelial Cells | 1 | 2019 | 685 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2017 | 245 | 0.120 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 287 | 0.110 |
Why?
| | Tyrosine | 1 | 2014 | 216 | 0.110 |
Why?
| | Cadmium | 1 | 2014 | 58 | 0.110 |
Why?
| | Tryptophan | 1 | 2014 | 135 | 0.110 |
Why?
| | Kidney | 2 | 2023 | 1184 | 0.110 |
Why?
| | Azoles | 1 | 2012 | 4 | 0.100 |
Why?
| | Chromatography, Liquid | 4 | 2017 | 348 | 0.100 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2014 | 162 | 0.100 |
Why?
| | Auditory Perception | 1 | 1993 | 102 | 0.100 |
Why?
| | Phenylenediamines | 1 | 2012 | 5 | 0.100 |
Why?
| | Organoselenium Compounds | 1 | 2012 | 11 | 0.100 |
Why?
| | Esthetics | 1 | 1992 | 37 | 0.100 |
Why?
| | Surgery, Plastic | 1 | 1992 | 25 | 0.100 |
Why?
| | Alkylation | 1 | 2012 | 18 | 0.100 |
Why?
| | Amino Acids, Sulfur | 1 | 2011 | 8 | 0.100 |
Why?
| | Otitis Media | 1 | 1994 | 143 | 0.100 |
Why?
| | Sweetening Agents | 1 | 2011 | 37 | 0.100 |
Why?
| | Immunoassay | 1 | 2012 | 95 | 0.100 |
Why?
| | Fatty Liver, Alcoholic | 1 | 2011 | 16 | 0.090 |
Why?
| | Fructose | 1 | 2011 | 100 | 0.090 |
Why?
| | Biomarkers | 3 | 2021 | 3418 | 0.090 |
Why?
| | Neurotoxicity Syndromes | 1 | 2011 | 14 | 0.090 |
Why?
| | Carcinoma, Basal Cell | 1 | 1992 | 68 | 0.090 |
Why?
| | Regression Analysis | 1 | 2013 | 947 | 0.090 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2011 | 71 | 0.090 |
Why?
| | Sirtuin 3 | 1 | 2011 | 52 | 0.090 |
Why?
| | Cytochromes c | 1 | 2010 | 63 | 0.090 |
Why?
| | Triglycerides | 2 | 2011 | 470 | 0.090 |
Why?
| | Acetylation | 3 | 2017 | 211 | 0.090 |
Why?
| | Hepatocytes | 1 | 2011 | 196 | 0.090 |
Why?
| | Cardiolipins | 1 | 2010 | 72 | 0.080 |
Why?
| | Phylogeny | 1 | 2013 | 795 | 0.080 |
Why?
| | Buthionine Sulfoximine | 2 | 2023 | 8 | 0.080 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2011 | 139 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1440 | 0.080 |
Why?
| | Apolipoprotein B-100 | 1 | 2009 | 8 | 0.080 |
Why?
| | Fatty Liver | 1 | 2011 | 213 | 0.080 |
Why?
| | Dietary Fats | 1 | 2011 | 287 | 0.080 |
Why?
| | Infant, Newborn | 1 | 2019 | 5035 | 0.080 |
Why?
| | Pilot Projects | 1 | 2013 | 1372 | 0.080 |
Why?
| | Endoplasmic Reticulum | 1 | 2011 | 234 | 0.080 |
Why?
| | Alcoholism | 1 | 2015 | 715 | 0.080 |
Why?
| | Cytochrome P-450 CYP2E1 | 1 | 2008 | 27 | 0.080 |
Why?
| | Animal Feed | 1 | 2008 | 49 | 0.080 |
Why?
| | Protein Binding | 1 | 2014 | 1897 | 0.080 |
Why?
| | Dopamine | 1 | 2011 | 235 | 0.080 |
Why?
| | NF-kappa B | 2 | 2011 | 637 | 0.080 |
Why?
| | Molecular Conformation | 1 | 2008 | 138 | 0.080 |
Why?
| | Protein Processing, Post-Translational | 1 | 2010 | 399 | 0.080 |
Why?
| | Cell Nucleus | 1 | 2011 | 554 | 0.080 |
Why?
| | Head and Neck Neoplasms | 1 | 1992 | 436 | 0.070 |
Why?
| | Oxygen | 1 | 2012 | 853 | 0.070 |
Why?
| | Models, Molecular | 2 | 2011 | 1379 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2008 | 278 | 0.070 |
Why?
| | Disease Progression | 1 | 2013 | 2392 | 0.070 |
Why?
| | Sex Factors | 1 | 2012 | 1721 | 0.070 |
Why?
| | Glucose | 1 | 2011 | 897 | 0.070 |
Why?
| | Glutathione Transferase | 2 | 2017 | 94 | 0.070 |
Why?
| | Signal Transduction | 3 | 2018 | 4525 | 0.070 |
Why?
| | Glycosylation | 2 | 2019 | 130 | 0.060 |
Why?
| | Proteome | 2 | 2023 | 339 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 995 | 0.060 |
Why?
| | Influenza, Human | 1 | 2011 | 546 | 0.060 |
Why?
| | Skin Neoplasms | 1 | 1992 | 762 | 0.060 |
Why?
| | RNA, Messenger | 2 | 2011 | 2559 | 0.060 |
Why?
| | Case-Control Studies | 3 | 2018 | 3008 | 0.060 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1635 | 0.060 |
Why?
| | Phosphorylation | 1 | 2008 | 1572 | 0.060 |
Why?
| | HEK293 Cells | 2 | 2019 | 593 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 1 | 2008 | 2211 | 0.060 |
Why?
| | Gene Expression | 1 | 2008 | 1422 | 0.050 |
Why?
| | Transcription Factors | 1 | 2011 | 1530 | 0.050 |
Why?
| | Neurons | 1 | 2011 | 1282 | 0.050 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2023 | 96 | 0.050 |
Why?
| | Mice, Knockout | 1 | 2009 | 2587 | 0.050 |
Why?
| | Click Chemistry | 1 | 2023 | 48 | 0.050 |
Why?
| | Adult | 5 | 2017 | 30608 | 0.050 |
Why?
| | Glutathione Disulfide | 2 | 2013 | 26 | 0.050 |
Why?
| | Silicon Dioxide | 1 | 2023 | 88 | 0.050 |
Why?
| | Acoustic Stimulation | 2 | 1994 | 315 | 0.050 |
Why?
| | Aged | 3 | 2017 | 19122 | 0.050 |
Why?
| | Mammals | 1 | 2023 | 245 | 0.050 |
Why?
| | Eye Proteins | 1 | 2021 | 71 | 0.050 |
Why?
| | Diet | 1 | 2008 | 1077 | 0.050 |
Why?
| | Adenosylhomocysteinase | 1 | 2021 | 10 | 0.050 |
Why?
| | Glycine Hydroxymethyltransferase | 1 | 2021 | 15 | 0.050 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2021 | 34 | 0.050 |
Why?
| | Polyamines | 1 | 2021 | 39 | 0.050 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2023 | 359 | 0.050 |
Why?
| | Betaine | 1 | 2021 | 63 | 0.050 |
Why?
| | Inflammation | 1 | 2011 | 2485 | 0.050 |
Why?
| | Seizures | 1 | 2023 | 340 | 0.040 |
Why?
| | Rats | 1 | 2008 | 4963 | 0.040 |
Why?
| | Homocysteine | 1 | 2021 | 136 | 0.040 |
Why?
| | Uterine Artery | 1 | 2020 | 67 | 0.040 |
Why?
| | Lactoylglutathione Lyase | 1 | 2019 | 6 | 0.040 |
Why?
| | Middle Aged | 3 | 2017 | 26806 | 0.040 |
Why?
| | Carrier Proteins | 2 | 2017 | 696 | 0.040 |
Why?
| | Folic Acid | 1 | 2021 | 161 | 0.040 |
Why?
| | Alkynes | 1 | 2019 | 53 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2021 | 429 | 0.040 |
Why?
| | Amino Acid Sequence | 2 | 2015 | 1988 | 0.040 |
Why?
| | Solubility | 1 | 2019 | 224 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2015 | 2791 | 0.040 |
Why?
| | Surface Properties | 1 | 2019 | 387 | 0.040 |
Why?
| | Heme Oxygenase-1 | 1 | 2018 | 52 | 0.040 |
Why?
| | Estrogens | 1 | 2020 | 312 | 0.040 |
Why?
| | Azo Compounds | 1 | 2017 | 25 | 0.040 |
Why?
| | Catalase | 1 | 2017 | 117 | 0.040 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2017 | 61 | 0.040 |
Why?
| | Retrospective Studies | 1 | 2013 | 12544 | 0.040 |
Why?
| | Homeostasis | 1 | 2020 | 576 | 0.040 |
Why?
| | Chronic Disease | 2 | 2011 | 1593 | 0.030 |
Why?
| | Glutathione Reductase | 1 | 2015 | 21 | 0.030 |
Why?
| | Toxicity Tests, Acute | 1 | 2014 | 9 | 0.030 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2014 | 76 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2015 | 156 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 1994 | 4427 | 0.030 |
Why?
| | Tympanoplasty | 1 | 1994 | 7 | 0.030 |
Why?
| | Hearing Loss, Conductive | 1 | 1994 | 22 | 0.030 |
Why?
| | Ossicular Prosthesis | 1 | 1994 | 17 | 0.030 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2014 | 31 | 0.030 |
Why?
| | Fourier Analysis | 1 | 2014 | 39 | 0.030 |
Why?
| | Acoustics | 1 | 1994 | 46 | 0.030 |
Why?
| | Auranofin | 1 | 2013 | 9 | 0.030 |
Why?
| | Amplifiers, Electronic | 1 | 1993 | 9 | 0.030 |
Why?
| | Auditory Threshold | 1 | 1993 | 40 | 0.030 |
Why?
| | Ear, Middle | 1 | 1993 | 89 | 0.030 |
Why?
| | Noise | 1 | 1993 | 68 | 0.030 |
Why?
| | DNA Primers | 1 | 2014 | 514 | 0.030 |
Why?
| | Isoindoles | 1 | 2012 | 4 | 0.030 |
Why?
| | Prosthesis Design | 1 | 1994 | 285 | 0.030 |
Why?
| | Administration, Oral | 1 | 2014 | 731 | 0.030 |
Why?
| | Facial Neoplasms | 1 | 1992 | 17 | 0.030 |
Why?
| | Hearing | 1 | 1993 | 136 | 0.020 |
Why?
| | Time Factors | 2 | 2014 | 6125 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 929 | 0.020 |
Why?
| | Nuclear Localization Signals | 1 | 2011 | 14 | 0.020 |
Why?
| | Biological Assay | 1 | 2011 | 113 | 0.020 |
Why?
| | Microsomes, Liver | 1 | 2011 | 57 | 0.020 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2011 | 101 | 0.020 |
Why?
| | Metabolic Detoxication, Phase I | 1 | 2010 | 4 | 0.020 |
Why?
| | Surgical Flaps | 1 | 1992 | 121 | 0.020 |
Why?
| | Molecular Structure | 1 | 2012 | 438 | 0.020 |
Why?
| | NAD | 1 | 2011 | 64 | 0.020 |
Why?
| | Orthomyxoviridae Infections | 1 | 2011 | 54 | 0.020 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2010 | 45 | 0.020 |
Why?
| | Stereoisomerism | 1 | 2010 | 91 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2011 | 325 | 0.020 |
Why?
| | Cytoplasm | 1 | 2011 | 255 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 1856 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 752 | 0.020 |
Why?
| | Base Sequence | 1 | 2014 | 2118 | 0.020 |
Why?
| | Wound Healing | 1 | 1992 | 258 | 0.020 |
Why?
| | Protein Subunits | 1 | 2010 | 201 | 0.020 |
Why?
| | Pregnancy | 1 | 2020 | 5527 | 0.020 |
Why?
| | Intracellular Space | 1 | 2009 | 68 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2010 | 855 | 0.020 |
Why?
| | Tubulin | 1 | 2009 | 123 | 0.020 |
Why?
| | Cell Death | 1 | 2009 | 325 | 0.020 |
Why?
| | Neoplasm Recurrence, Local | 1 | 1992 | 863 | 0.020 |
Why?
| | Models, Biological | 1 | 1994 | 1630 | 0.020 |
Why?
| | Microtubules | 1 | 2009 | 237 | 0.020 |
Why?
| | Glucocorticoids | 1 | 2011 | 534 | 0.020 |
Why?
| | Weight Loss | 1 | 2011 | 642 | 0.020 |
Why?
| | Lipids | 1 | 2009 | 582 | 0.020 |
Why?
| | Cytokines | 1 | 2011 | 1843 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2009 | 2199 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 1992 | 6364 | 0.010 |
Why?
|
|
Roede's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|